These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26113842)

  • 1. The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.
    Navari M; Etebari M; De Falco G; Ambrosio MR; Gibellini D; Leoncini L; Piccaluga PP
    Front Microbiol; 2015; 6():556. PubMed ID: 26113842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
    Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
    Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.
    Navari M; Fuligni F; Laginestra MA; Etebari M; Ambrosio MR; Sapienza MR; Rossi M; De Falco G; Gibellini D; Tripodo C; Pileri SA; Leoncini L; Piccaluga PP
    Front Microbiol; 2014; 5():728. PubMed ID: 25566237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.
    Lenze D; Leoncini L; Hummel M; Volinia S; Liu CG; Amato T; De Falco G; Githanga J; Horn H; Nyagol J; Ott G; Palatini J; Pfreundschuh M; Rogena E; Rosenwald A; Siebert R; Croce CM; Stein H
    Leukemia; 2011 Dec; 25(12):1869-1876. PubMed ID: 21701491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and
    Liao HM; Liu H; Chin PJ; Li B; Hung GC; Tsai S; Otim I; Legason ID; Ogwang MD; Reynolds SJ; Kerchan P; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Ayers LW; Pfeiffer RM; Bhatia K; Goedert JJ; Lo SC; Mbulaiteye SM
    Front Oncol; 2022; 12():812224. PubMed ID: 35340265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma.
    Ambrosio MR; Navari M; Di Lisio L; Leon EA; Onnis A; Gazaneo S; Mundo L; Ulivieri C; Gomez G; Lazzi S; Piris MA; Leoncini L; De Falco G
    Infect Agent Cancer; 2014; 9():12. PubMed ID: 24731550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma.
    El-Mallawany NK; Day N; Ayello J; Van de Ven C; Conlon K; Fermin D; Basrur V; Elenitoba-Johnson K; Lim M; Cairo MS
    Eur J Cancer; 2015 Jan; 51(1):92-100. PubMed ID: 25466511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants.
    Rochford R
    Ann Lymphoma; 2021 Sep; 5():. PubMed ID: 34888589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
    Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
    Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
    Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
    Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
    Klein G; Klein E; Kashuba E
    Biochem Biophys Res Commun; 2010 May; 396(1):67-73. PubMed ID: 20494113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma.
    Oduor CI; Movassagh M; Kaymaz Y; Chelimo K; Otieno J; Ong'echa JM; Moormann AM; Bailey JA
    Front Microbiol; 2017; 8():501. PubMed ID: 28400759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiological analysis and literature review of the prevalence of Epstein-Barr virus and herpesvirus infections in pediatric cases with non-Hodgkin lymphoma in Central Europe.
    Vaillant V; Reiter A; Zimmermann M; Wagner HJ
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27752. PubMed ID: 30977593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    Rooney C; Howe JG; Speck SH; Miller G
    J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.